Prelude Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-6,415
| Closed | -$1.45M | – | 1242 |
|
2023
Q3 | $1.45M | Buy |
+6,415
| New | +$1.45M | 0.09% | 201 |
|
2021
Q3 | – | Sell |
-33,635
| Closed | -$6.03M | – | 1729 |
|
2021
Q2 | $6.03M | Buy |
33,635
+11,160
| +50% | +$2M | 0.18% | 49 |
|
2021
Q1 | $3.76M | Buy |
22,475
+615
| +3% | +$103K | 0.1% | 72 |
|
2020
Q4 | $3.32M | Buy |
21,860
+20,998
| +2,436% | +$3.19M | 0.08% | 64 |
|
2020
Q3 | $87K | Sell |
862
-3,318
| -79% | -$335K | ﹤0.01% | 728 |
|
2020
Q2 | $506K | Buy |
+4,180
| New | +$506K | 0.03% | 283 |
|
2019
Q3 | – | Sell |
-222
| Closed | -$17K | – | 1590 |
|
2019
Q2 | $17K | Buy |
+222
| New | +$17K | ﹤0.01% | 950 |
|
2017
Q4 | – | Sell |
-2,406
| Closed | -$282K | – | 1598 |
|
2017
Q3 | $282K | Buy |
+2,406
| New | +$282K | 0.03% | 481 |
|
2017
Q1 | – | Sell |
-2,888
| Closed | -$414K | – | 1736 |
|
2016
Q4 | $414K | Buy |
+2,888
| New | +$414K | 0.05% | 322 |
|
2016
Q3 | – | Sell |
-1,981
| Closed | -$210K | – | 1759 |
|
2016
Q2 | $210K | Sell |
1,981
-4,504
| -69% | -$477K | 0.03% | 442 |
|
2016
Q1 | $723K | Sell |
6,485
-708
| -10% | -$78.9K | 0.1% | 191 |
|
2015
Q4 | $1.13M | Buy |
7,193
+4,345
| +153% | +$680K | 0.17% | 125 |
|
2015
Q3 | $374K | Sell |
2,848
-559
| -16% | -$73.4K | 0.05% | 314 |
|
2015
Q2 | $593K | Sell |
3,407
-640
| -16% | -$111K | 0.08% | 255 |
|
2015
Q1 | $698K | Sell |
4,047
-334
| -8% | -$57.6K | 0.1% | 245 |
|
2014
Q4 | $567K | Sell |
4,381
-1,927
| -31% | -$249K | 0.08% | 250 |
|
2014
Q3 | $812K | Buy |
6,308
+674
| +12% | +$86.8K | 0.11% | 200 |
|
2014
Q2 | $499K | Sell |
5,634
-2,098
| -27% | -$186K | 0.07% | 333 |
|
2014
Q1 | $727K | Buy |
7,732
+1,856
| +32% | +$175K | 0.1% | 241 |
|
2013
Q4 | $664K | Buy |
5,876
+1,780
| +43% | +$201K | 0.11% | 231 |
|
2013
Q3 | $323K | Sell |
4,096
-8,257
| -67% | -$651K | 0.05% | 343 |
|
2013
Q2 | $813K | Buy |
+12,353
| New | +$813K | 0.17% | 115 |
|